Literature DB >> 12695560

Terminal renal failure in mice lacking transcription factor AP-2 beta.

Markus Moser1, Sandra Dahmen, Reinhart Kluge, Hermann Gröne, Judith Dahmen, Dagmar Kunz, Hubert Schorle, Reinhard Buettner.   

Abstract

Inactivation of the transcription factor AP-2 beta in a genetically mixed C57BL/6/129S1 mouse strain resulted in perinatal lethality as a consequence of massively enhanced apoptotic death of renal epithelial cells (Genes Dev 1997;11:1938-1948). Recently, we observed that the phenotype is modulated by genetic background because AP-2 beta mutant mice, backcrossed onto 129P2 background, survive approximately 2 weeks after birth, allowing for a detailed analysis of kidney function. Here we show that kidneys reveal varying amounts of cysts derived from all tubular structures (proximal and distal tubuli, collecting ducts). However, all mice died irrespective of the degree of cyst formation. Serum analysis of AP-2 beta mutant animals revealed defective tubular secretory function and ion homeostasis including severe hypocalcemia, hyperphosphatemia, and hyperuremia. Because hormonal calcium regulation was not impaired, the mice developed secondary renal hyperparathyroidism as typically observed in patients with terminal renal failure. We further demonstrate that molecular defects in the collecting duct system lead to insufficient water retention and urinary concentration. In summary, our studies reveal essential, nonredundant roles of AP-2 beta in renal tubular functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695560     DOI: 10.1097/01.lab.0000064703.92382.50

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  AP-2β/KCTD1 Control Distal Nephron Differentiation and Protect against Renal Fibrosis.

Authors:  Alexander G Marneros
Journal:  Dev Cell       Date:  2020-06-17       Impact factor: 12.270

2.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Authors:  Zakir Hossain; Safiah Mohamed Ali; Hui Ling Ko; Jianliang Xu; Chee Peng Ng; Ke Guo; Zeng Qi; Sathivel Ponniah; Wanjin Hong; Walter Hunziker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

3.  Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.

Authors:  Yi-Wei Chen; Wu Zhao; Zhi-Fang Zhang; Qihua Fu; Jie Shen; Zhen Zhang; Wei Ji; Jian Wang; Fen Li
Journal:  Pediatr Cardiol       Date:  2011-06-04       Impact factor: 1.655

4.  Aberrant expressions of AP-2α splice variants in pancreatic cancer.

Authors:  Catherine Carrière; Sarah Mirocha; Sophie Deharvengt; Jason R Gunn; Murray Korc
Journal:  Pancreas       Date:  2011-07       Impact factor: 3.327

5.  Comparative transcriptomic analysis identifies evolutionarily conserved gene products in the vertebrate renal distal convoluted tubule.

Authors:  Yuya Sugano; Chiara Cianciolo Cosentino; Dominique Loffing-Cueni; Stephan C F Neuhauss; Johannes Loffing
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

6.  Sleep Architecture in Mice Is Shaped by the Transcription Factor AP-2β.

Authors:  Ayaka Nakai; Tomoyuki Fujiyama; Nanae Nagata; Mitsuaki Kashiwagi; Aya Ikkyu; Marina Takagi; Chika Tatsuzawa; Kaeko Tanaka; Miyo Kakizaki; Mika Kanuka; Taizo Kawano; Seiya Mizuno; Fumihiro Sugiyama; Satoru Takahashi; Hiromasa Funato; Takeshi Sakurai; Masashi Yanagisawa; Yu Hayashi
Journal:  Genetics       Date:  2020-09-02       Impact factor: 4.562

7.  Transcriptional regulation during development of the ductus arteriosus.

Authors:  Kathryn N Ivey; David Sutcliffe; James Richardson; Ronald I Clyman; Joseph A Garcia; Deepak Srivastava
Journal:  Circ Res       Date:  2008-07-17       Impact factor: 17.367

8.  Tfap2a is a novel gatekeeper of nephron differentiation during kidney development.

Authors:  Brooke E Chambers; Gary F Gerlach; Eleanor G Clark; Karen H Chen; Anna E Levesque; Ignaty Leshchiner; Wolfram Goessling; Rebecca A Wingert
Journal:  Development       Date:  2019-07-10       Impact factor: 6.868

Review 9.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

10.  CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD.

Authors:  Nikolay O Bukanov; Sarah E Moreno; Thomas A Natoli; Kelly A Rogers; Laurie A Smith; Steven R Ledbetter; Nassima Oumata; Hervé Galons; Laurent Meijer; Oxana Ibraghimov-Beskrovnaya
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.